NECCR Phase I Capabilities Are Here
Powered by Prima CARE & Bioskills of the North East.
Purpose-Built for Research. Designed for More
Phase II–IV pharmaceutical trials, advanced laboratory services & medical device research.
Clinical Trial Population Intelligence Platform
In collaboration with Santovia Path AI and Bioskills of the North East, NECCR is developing population-level intelligence designed to support smarter feasibility, site selection and recruitment planning.
New England Center for Clinical Research
NECCR combines the reach of an integrated healthcare network with the agility of an independent research site, connecting sponsors and CROs with experienced investigators, diverse patient populations, and efficient trial execution, with a singular vision:
To build the nation’s leading multi-therapeutic clinical research site.
Therapeutic Specialties
Internal Medicine & Cardiology
Cardiovascular and internal medicine trials across a broad patient population.
Women's Health
Clinical trials spanning a range of women’s health conditions and therapeutic needs.
Obesity and Endocrinology
Research in obesity, diabetes, metabolic disorders, and endocrine conditions.
Allergy and Pulmonology
Research across respiratory, pulmonary, allergic, and immunologic conditions.
Device Usability
Usability and human factors research evaluating patient and clinician interaction with medical devices.
Medical Devices
Clinical research evaluating the safety, performance, and use of medical devices.
Research Laboratory Services
Research-focused laboratory services supporting protocol requirements, specimen processing, and study-specific testing.
Gastroenterology
Clinical trials across gastrointestinal and digestive diseases and conditions.
Rheumatology
Clinical trials across rheumatic, inflammatory, and autoimmune conditions.
Neurology
Clinical trials across neurological, cognitive, and central nervous system diseases and conditions.
Solutions Overview
Phase I
This state-of-the-art Phase 1 clinical research unit crowns our three-building medical campus. Backed by 185+ experienced practitioners and 200,000 patients, our integrated network ensures fast, dependable study enrollment and robust clinical execution.
Phase II-IV
An integrated model for late-phase clinical trials, bringing together experienced investigators, dedicated research professionals, an established patient population, and specialized operational infrastructure.
Biobank and Prospective Specimen Procurement
Collection and procurement of high-quality biospecimens from characterized patient populations.
AI Powered Trial Enablement
AI-enabled pathology and clinical data intelligence to support more efficient patient identification, eligibility assessment, and trial enrollment.
Research Facilities and Capabilities
A highly adaptable clinical and procedural environment combining specialized research space, advanced imaging, and infrastructure to support Phase I–IV clinical trials.
Client Experiences That Speak for Themselves











